TheProductLawyers.com reports on possible IVC filter failures which have been noted by patients, some of which are significantly dangerous and have allegedly left patients in both pain and significant fear of future complications. Several IVC filter patients now report that they have been left with shattered pieces of the devices spread throughout their bodies which have traveled and become embedded in areas that are too risky to attempt to surgically remove them. Many of these patients say that they are left wondering when the devices will move again, causing them more harm.
For one plaintiff from South Dakota, an Eclipse IVC filter manufactured by C.R. Bard was implanted in her body in order to lower the risk of blood clots traveling from the lower body toward the lungs and heart and causing pulmonary embolism. IVC filters are surgically implanted into patients’ inferior vena cava veins. As with all IVC filter devices, the woman’s filter was supposed to be used temporarily while she was deemed at increased risk for the development of blood clots and then later removed when this risk was no longer present.
The plaintiff indicates, however, that instead of being removed, the filter is now permanently stuck in her body. She claims that it migrated from its insertion location and continued to travel within the body until it became lodged within her internal organs. She notes that even an attempted surgical removal of the filter was unsuccessful, and therefore, to this day, she believes that it places her at risk for increased complications; possibly even life-threatening ones. Each day, she noted that she lives with the fear of knowing that the possibility of a sudden catastrophic event could occur within her body at any point.
The U.S. Food and Drug Administration (FDA) has indicated that in 2010 that they had received 900 or more adverse event reports referring to inferior vena cava (IVC) perforation, filter migration, filter breakage, and embolization. The agency has released a public safety communication to the medical community concerning these noted dangers and indicating that IVC filters are to ideally be retrieved from patients 29 to 54 days after implantation, if the blood clot risk has subsided.
As lawsuits discussing various brands of these IVC devices continue to emerge, the attorneys of Banville Law are working to help others who believe they have suffered from health complications after having an IVC filter implanted. Patients who have been affected could be entitled to significant compensation. The attorneys of Banville Law believe that all involved patients are deserving of utilizing the important opportunity to evaluate their legal rights in full, and are therefore now offering complimentary legal consultations for these individuals.
To request additional information, or to ask questions at any time, please contact the attorneys of Banville Law by calling 888-997-3792.
###
Contact TheProductLawyers.com:
Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h, New York, NY 10023
